Kangmei Pharma | 600518 - Los Gastos Financieros De La Deuda





Los Gastos Financieros De La Deuda Cambio Fecha
Akebia Therapeutics 349.66M 12.86M 2026-06
Alaunos Therapeutics USD 1.07M 215K 2023-06
Avita Medical AUD 1.25M 100K 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Dianthus Therapeutics USD 4.44M 263K 2024-09
Genomma Lab Internacional MXN 190.68M 972K 2025-12
Hypermarcas BRL 36.54M 3.75M 2025-12
Ionis Pharmaceuticals USD 18M 1000K 2026-06
IQVIA Holdings USD 197M 5M 2026-06
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Moderna USD 10.96B 527M 2026-06
Organon & Co USD 108M 3M 2026-06
Revvity USD 22.99M 1.73M 2026-06
Sh Fosun Pharma CNY 321.25M 2M 2025-09
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Viatris USD 120.7M 600K 2026-06
Wuxi Apptec CNY 103.05M 37.29M 2025-06
Xeris Pharmaceuticals USD 6.88M 269K 2026-03
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06